We also observed a downtrend in the proportion of CXCL13+ CAFs in NPC samples from early to advanced stages (Fig. 5c), resembling that of GC B cells and antibody level (Fig. 2b–d). Here, CXCL13 is linked to nasopharyngeal carcinoma.